FAC Explorer

Finding 1150654 (2021-014)

Material Weakness
Requirement
H
Questioned Costs
-
Year
2021
Accepted
2025-08-22
Audit: 364763
Organization: South Central Medical and Resource Center, Inc. (OK)
Auditor: Johnston and Bryant Certified Public Accountants

AI Summary

  • Answer: Regular internal audits should be conducted to check compliance with grant timelines and performance periods.
  • Trend: This practice helps identify any delays or issues early, ensuring grants are managed effectively.
  • List: Set up a schedule for these audits to maintain oversight and improve grant management processes.

Finding Text

6. Institute periodic internal audit or monitoring reviews of grant timelines and period-of-performance compliance.

Categories

Subrecipient Monitoring

Other Findings in this Audit

  • 574199 2021-001
    Material Weakness
  • 574200 2021-002
    Material Weakness
  • 574201 2021-003
    Significant Deficiency
  • 574202 2021-004
    Material Weakness
  • 574203 2021-005
    Significant Deficiency
  • 574204 2021-006
    Significant Deficiency
  • 574205 2021-007
    Significant Deficiency
  • 574206 2021-008
    Significant Deficiency
  • 574207 2021-009
    Material Weakness
  • 574208 2021-010
    Material Weakness
  • 574209 2021-011
    Material Weakness
  • 574210 2021-012
    Material Weakness
  • 574211 2021-013
    Material Weakness
  • 574212 2021-014
    Material Weakness
  • 574213 2021-015
    Material Weakness
  • 574214 2021-016
    Material Weakness
  • 574215 2021-001
    Material Weakness
  • 574216 2021-002
    Material Weakness
  • 574217 2021-003
    Significant Deficiency
  • 574218 2021-004
    Material Weakness
  • 574219 2021-005
    Significant Deficiency
  • 574220 2021-006
    Significant Deficiency
  • 574221 2021-007
    Significant Deficiency
  • 574222 2021-008
    Significant Deficiency
  • 574223 2021-009
    Material Weakness
  • 574224 2021-010
    Material Weakness
  • 574225 2021-011
    Material Weakness
  • 574226 2021-012
    Material Weakness
  • 574227 2021-013
    Material Weakness
  • 574228 2021-014
    Material Weakness
  • 574229 2021-015
    Material Weakness
  • 574230 2021-016
    Material Weakness
  • 574231 2021-001
    Material Weakness
  • 574232 2021-002
    Material Weakness
  • 574233 2021-003
    Significant Deficiency
  • 574234 2021-004
    Material Weakness
  • 574235 2021-005
    Significant Deficiency
  • 574236 2021-006
    Significant Deficiency
  • 574237 2021-007
    Significant Deficiency
  • 574238 2021-008
    Significant Deficiency
  • 574239 2021-009
    Material Weakness
  • 574240 2021-010
    Material Weakness
  • 574241 2021-011
    Material Weakness
  • 574242 2021-012
    Material Weakness
  • 574243 2021-013
    Material Weakness
  • 574244 2021-014
    Material Weakness
  • 574245 2021-015
    Material Weakness
  • 574246 2021-016
    Material Weakness
  • 1150641 2021-001
    Material Weakness
  • 1150642 2021-002
    Material Weakness
  • 1150643 2021-003
    Significant Deficiency
  • 1150644 2021-004
    Material Weakness
  • 1150645 2021-005
    Significant Deficiency
  • 1150646 2021-006
    Significant Deficiency
  • 1150647 2021-007
    Significant Deficiency
  • 1150648 2021-008
    Significant Deficiency
  • 1150649 2021-009
    Material Weakness
  • 1150650 2021-010
    Material Weakness
  • 1150651 2021-011
    Material Weakness
  • 1150652 2021-012
    Material Weakness
  • 1150653 2021-013
    Material Weakness
  • 1150655 2021-015
    Material Weakness
  • 1150656 2021-016
    Material Weakness
  • 1150657 2021-001
    Material Weakness
  • 1150658 2021-002
    Material Weakness
  • 1150659 2021-003
    Significant Deficiency
  • 1150660 2021-004
    Material Weakness
  • 1150661 2021-005
    Significant Deficiency
  • 1150662 2021-006
    Significant Deficiency
  • 1150663 2021-007
    Significant Deficiency
  • 1150664 2021-008
    Significant Deficiency
  • 1150665 2021-009
    Material Weakness
  • 1150666 2021-010
    Material Weakness
  • 1150667 2021-011
    Material Weakness
  • 1150668 2021-012
    Material Weakness
  • 1150669 2021-013
    Material Weakness
  • 1150670 2021-014
    Material Weakness
  • 1150671 2021-015
    Material Weakness
  • 1150672 2021-016
    Material Weakness
  • 1150673 2021-001
    Material Weakness
  • 1150674 2021-002
    Material Weakness
  • 1150675 2021-003
    Significant Deficiency
  • 1150676 2021-004
    Material Weakness
  • 1150677 2021-005
    Significant Deficiency
  • 1150678 2021-006
    Significant Deficiency
  • 1150679 2021-007
    Significant Deficiency
  • 1150680 2021-008
    Significant Deficiency
  • 1150681 2021-009
    Material Weakness
  • 1150682 2021-010
    Material Weakness
  • 1150683 2021-011
    Material Weakness
  • 1150684 2021-012
    Material Weakness
  • 1150685 2021-013
    Material Weakness
  • 1150686 2021-014
    Material Weakness
  • 1150687 2021-015
    Material Weakness
  • 1150688 2021-016
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $445,622
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $166,795